Table 1. Demographic datas, laboratory findings, follow up, Hospital Anxiety and Depression Scale, General Health Questionnaire, Eastern Cooperative Oncology Group and Karnofsky scores, general medical, functional and symptom scales of European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 between 1^st generation tyrosine kinase inhibitor and 2^nd generation tyrosine kinase inhibitor (dasatinib and nilotinib).